Since years Talley and his board buddies unsuccessfully try to find a pharma partner for Amiket (R). Apparently represents also this cream no significant medical market value for pharma. A further part in their long history of incompetence,of blatant failures and cheeky self-service actions. Talley does not offer drug products. He invents stories about the alleged value of some drug candidates and misleads that way stockholders. The never ending story with the "break through" Ceplene is an example. Now they offer their next idea: The sale of the whole. However there is still a problem: Talley must at first find someone who is ready to buy his junk stories.